Stocks
Alnylam Pharmaceuticals (ALNY) Operating Income US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| Operating Income, bln rub | -939.4 | -828.4 | -708.7 | -785.1 | -282.2 | -188.1 | |||
| Changes by years, y/y, % | +15% | -12% | -14% | +11% | -64% | -19.1% | |||
Alnylam Pharmaceuticals. Operating Income, bln rub
Alnylam Pharmaceuticals. Operating Income, changes, %
Alnylam Pharmaceuticals. Operating Income, sum by quarters, bln rub
Alnylam Pharmaceuticals (ALNY) Operating Income US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| Operating Income, bln rub | 213.9 | -116.4 | -43.4 | 48.6 | -76.9 | -188.1 | ||
| Changes by years, y/y, % | -183% | -38% | -71% | -121% | -136% | |||
| Changes by quarters, q/q, % | -193% | -154% | -63% | -212% | -258% | |||
